Litcius/Paper detail

Mapping the Phospho-dependent ALK Interactome to Identify Novel Components in ALK Signaling

Farzaneh Aboualizadeh, Zhong Yao, Jikui Guan, Luka Drecun, Shivanthy Pathmanathan, Jamie Snider, Ganesh Umapathy, Max Kotlyar, Igor Jurišica, Ruth H. Palmer, Igor Štagljar

2021Journal of Molecular Biology12 citationsDOIOpen Access PDF

Abstract

Protein-protein interactions (PPIs) play essential roles in Anaplastic Lymphoma Kinase (ALK) signaling. Systematic characterization of ALK interactors helps elucidate novel ALK signaling mechanisms and may aid in the identification of novel therapeutics targeting related diseases. In this study, we used the Mammalian Membrane Two-Hybrid (MaMTH) system to map the phospho-dependent ALK interactome. By screening a library of 86 SH2 domain-containing full length proteins, 30 novel ALK interactors were identified. Many of their interactions are correlated to ALK phosphorylation activity: oncogenic ALK mutations potentiate the interactions and ALK inhibitors attenuate the interactions. Among the novel interactors, NCK2 was further verified in neuroblastoma cells using co-immunoprecipitation. Modulation of ALK activity by addition of inhibitors lead to concomitant changes in the tyrosine phosphorylation status of NCK2 in neuroblastoma cells, strongly supporting the functionality of the ALK/NCK2 interaction. Our study provides a resource list of potential novel ALK signaling components for further study.

Topics & Concepts

InteractomeAnaplastic lymphoma kinaseImmunoprecipitationPhosphorylationSignal transductionProtein–protein interactionNeuroblastomaCancer researchComputational biologyChemistryALK inhibitorBiologyCell biologyBiochemistryGeneGeneticsCell cultureMedicineSurgeryMalignant pleural effusionPleural effusionNeuroblastoma Research and TreatmentsLung Cancer Treatments and MutationsLung Cancer Research Studies